What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Catalight study challenges ABA dosage norms: Real-world data shows more therapy hours don’t predict better adaptive outcomes Catalight’s new study challenges ABA dosage guidelines by showing that more therapy hours do not predict better adaptive outcomes. Read what this means. byPallavi MadhirajuJanuary 18, 2026